TALEN

TALEN1-pycr1a

ID
ZDB-TALEN-191025-1
Name
TALEN1-pycr1a
Previous Names
None
Target
Target Sequence 1
5' - CTGTACCTCAGAAAAT - 3'
Target Sequence 2
5' - CTCTTTATTACTGGT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
cy51 pycr1a
Expression
Gene expression in Wild Types + TALEN1-pycr1a
No data available
Phenotype
Phenotype resulting from TALEN1-pycr1a
No data available
Phenotype of all Fish created by or utilizing TALEN1-pycr1a
Phenotype Fish Conditions Figures
trunk neurotransmitter decreased amount, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
whole organism coenzyme Q10 decreased amount, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
retinal pigmented epithelium structure, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 2 with image from Liang et al., 2019
telomerase activity decreased efficacy, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
retinal neural layer disorganized, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 2 with image from Liang et al., 2019
whole organism chondroitin sulfate decreased amount, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
superoxide dismutase activity decreased efficacy, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
retinal outer nuclear layer has fewer parts of type eye photoreceptor cell, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 2 with image from Liang et al., 2019
exploration behavior decreased occurrence, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 4 with image from Liang et al., 2019
whole organism decreased length, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 2 with image from Liang et al., 2019
whole organism decreased weight, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 2 with image from Liang et al., 2019
antioxidant activity decreased efficacy, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
catalase activity decreased efficacy, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
circadian behavior disrupted, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
whole organism heparan sulfate decreased amount, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
whole organism senescent, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 2 with image from Liang et al., 2019
intestine increased permeability, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 2 with image from Liang et al., 2019
whole organism decreased life span, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 2 with image from Liang et al., 2019
whole organism hydroxyproline decreased amount, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
whole organism proline decreased amount, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
creatininase activity decreased efficacy, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
post-vent region apoptotic, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 2 with image from Liang et al., 2019
retinal inner nuclear layer has fewer parts of type interneuron, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 2 with image from Liang et al., 2019
behavioral defense response disrupted, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 4 with image from Liang et al., 2019
social behavior disrupted, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
whole organism ATP decreased amount, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
swimming decreased linear velocity, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 4 with image from Liang et al., 2019
whole organism decreased fecundity, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 2 with imagetext only from Liang et al., 2019
pleuroperitoneal region decreased size, abnormal pycr1acy51/cy51 (AB) standard conditions Figure 2 with image from Liang et al., 2019
whole organism keratan sulfate decreased amount, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
whole organism dermatan sulfate decreased amount, abnormal pycr1acy51/cy51 (AB) standard conditions text only from Liang et al., 2019
post-vent region apoptotic, abnormal pycr1acy51/+ (AB) standard conditions Figure 2 with image from Liang et al., 2019
Citations